|
|
Office Locations:
|
Carnegie Hall Tower
152 West 57th Street, 59th Floor
New York, NY 10019
Phone: 646-840-4990
Fax: 212-419-3956
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Signet Healthcare partners was founded by James Gale and Sanders Morris Harris Group in 1998 with the establishment of the Corporate Opportunities Funds. Since 1998, the firm has organized four funds with aggregate capital commitments in excess of $400 million, and has invested in more than 45 companies. For the past nine years, Signet Healthcare has maintained its dedicated focus to diversified healthcare investing--primarily serving as lead investor to expansion stage companies engaged in specialty pharmaceuticals, medical devices and the pharma services industries. Since inception of Signet's Funds, the firm has invested on a global basis with approximately 20% of its funds committed to entities domiciled in Europe and Asia. Signet is currently making new investments out of its fourth fund, Fund IV. The Fund IV team is comprised of three senior investment professionals and a network of venture partners and operating advisors. A typical investment ranges from $10 million - $15 million per portfolio company.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
